BENGALURU (Reuters) - An expert committee of India's drug regulator recommended emergency use authorisation (EUA) for Merck's COVID-19 pill molnupiravir, and Serum Institute of India's Covovax and Biological E's corbevax vaccines, the Economic Times reported.
The recommendations by the subject expert committee have been sent to the Drugs Controller General of India, which will soon decide on their approval, according to the report on Tuesday.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!